top of page

News & Updates

Filter by:

Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study

News & Updates

26 Feb 2024

Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study

Read More
Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study
Interim Results from LIQUIK Prospective Study Released at WCLC 2023

News & Updates

8 Sept 2023

Interim Results from LIQUIK Prospective Study Released at WCLC 2023

Read More
Interim Results from LIQUIK Prospective Study Released at WCLC 2023
Lucence Announces CPT PLA Code Granted to LiquidHALLMARK®

News & Updates

7 Aug 2023

Lucence Announces CPT PLA Code Granted to LiquidHALLMARK®

Read More
Lucence Announces CPT PLA Code Granted to LiquidHALLMARK®
Lucence and Innovent Announce Strategic Collaboration on Bile Duct Cancer

News & Updates

24 Jul 2023

Lucence and Innovent Announce Strategic Collaboration on Bile Duct Cancer

Read More
Lucence and Innovent Announce Strategic Collaboration on Bile Duct Cancer
Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2023 ASCO Annual Meeting

News & Updates

26 May 2023

Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2023 ASCO Annual Meeting

Read More
Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2023 ASCO Annual Meeting
Lucence Launches LucenceINSIGHT to Detect Cancer Earlier

News & Updates

10 May 2023

Lucence Launches LucenceINSIGHT to Detect Cancer Earlier

Read More
Lucence Launches LucenceINSIGHT to Detect Cancer Earlier
Lucence secures US Medicare approval for its cancer tests

News & Updates

20 Mar 2023

Lucence secures US Medicare approval for its cancer tests

Read More
Lucence secures US Medicare approval for its cancer tests
Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

News & Updates

22 Feb 2023

Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

Read More
Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer
Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

News & Updates

23 Oct 2022

Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

Read More
Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

1

/

5

bottom of page